General characteristics of studies on the association of NLR with survival in tCa
Reference | Sample size | Study design | Year of publication | Country | Histopathology | Cut off value of NLR | Seminomatous tCa | Outcome |
---|---|---|---|---|---|---|---|---|
Arıman and Merder [27] | 152 | Retrospective cohort | 2021 | Turkey | tCa | 2.39 | 52.60% | Patients with good prognosis had statistically significant lower NLR than those with intermediate and poor prognosis. |
Tan et al. [2] | 160 | Retrospective cohort | 2019 | Singapore | tCa | 3 | 63.80% | High levels of NLR were associated with poorer CSS. |
Fankhauser et al. [31] | 146 | Retrospective cohort | 2018 | Switzerland | TGCT | 4.5 | 25.34% | NLR was an independent predictor of OS. |
Olcucu et al. [44] | 99 | Retrospective cohort | 2020 | Turkey | TGCT | 3.21 | 45.45% | Elevated NLR could predict metastasis and low mean survival time. |
Herraiz-Raya et al. [35] | 164 | Retrospective cohort | 2019 | Spain | TGCT | 4 | 50.00% | There was significant correlation between NLR and residual disease after chemotherapy and mean survival time of tCa patients. |
Yang et al. [50] | 2008–2016 | Retrospectivecohort | 2019 | China | tCa | 2.66 | - | High NLR was significantly associated with an elevated risk for disease progression. |
Karakaya et al. [39] | 40 | Retrospectivecohort | 2021 | Turkey | TGCT | - | 22.50% | NLR was a strong predictor of response to chemotherapy in tCa patients. |
Bauzá Quetglas et al. [46] | 80 | Retrospective cohort | 2020 | Spain | tCa | 2.25 | 62.50% | Pre-orchiectomy NLR was higher in patients who had adjuvant chemotherapy than those without chemotherapy.Post-orchiectomy NLR was related to the risk of recurrence and recurrence-free survival. |
Selvi and Başar [49] | 99 | Retrospective cohort | 2019 | Turkey | tCa | 3.23 | 60.00% | NLR was found to be significantly higher in patient with bilateral tCa than those with unilateral tCa. High NLR could predict contralateral tumor development. |
Arda et al. [26] | 182 | Retrospective cohort | 2020 | Turkey | TGCT | 1.78 | 46.60% | CSS was not different between patients with different NLR. |
Yoshinaga et al. [53] | 63 | Retrospective cohort | 2021 | Japan | TGCT | 4.1 | 27.00% | There was no significant association between PFS and OS and NLR. |
Pęksa et al. [45] | 180 | Retrospective cohort | 2021 | Poland | TGCT | 3.56 | 53.90% | NLR could not predict progression or relapse in tCa patients. |
Bolat et al. [29] | 53 | Retrospective cohort | 2017 | Turkey | TGCT | 3.35 | 50.90% | Time-to-cancer specific death between patients with different NLR was not significantly different. |
tCa: testicular cancer; TGCT: testicular germ cell tumor; NLR: neutrophil to lymphocyte ratio; CSS: cancer-specific survival; OS: overall survival; PFS: progression-free survival